EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 20 (2013) Parasite, 20 (2013) 19 References
Open Access
Issue
Parasite
Volume 20, 2013
Article Number 19
Number of page(s) 6
DOI https://doi.org/10.1051/parasite/2013020
Published online 27 May 2013
  1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annual Review of Pharmacology and Toxicology, 39, 361–398. [CrossRef] [PubMed] [Google Scholar]
  2. Aspinall TV, Joynson DH, Guy E, Hyde JE, Sims PF. 2002. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. Journal of Infectious Diseases, 185, 1637–1643. [CrossRef] [Google Scholar]
  3. Doliwa C, Escotte-Binet S, Aubert D, Velard F, Schmid A, Geers R, Villena I. 2013. Induction of sulfadiazine resistance in vitro in Toxoplasma gondii. Experimental Parasitology, 133, 131–136. [CrossRef] [PubMed] [Google Scholar]
  4. Grigg ME, Bonnefoy S, Hehl AB, Suzuki Y, Boothroyd JC. 2001. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science, 294, 161–165. [CrossRef] [PubMed] [Google Scholar]
  5. Howe DK, Sibley LD. 1995. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. Journal of Infectious Diseases, 172, 1561–1566. [CrossRef] [Google Scholar]
  6. Khan A, Behnke MS, Dunay IR, White MW, Sibley LD. 2009. Phenotypic and gene expression changes among clonal Type I strains of Toxoplasma gondii. Eukaryotic Cell, 8, 1828–1836. [CrossRef] [PubMed] [Google Scholar]
  7. Meneceur P, Bouldouyre MA, Aubert D, Villena I, Menotti J, Sauvage V, Garin JF, Derouin F. 2008. Toxoplasma gondii: in vitro susceptibility of various genotypic strains to pyrimethamine, sulfadiazine and atovaquone. Antimicrobial Agents and Chemotherapy, 52, 1269–1277. [CrossRef] [PubMed] [Google Scholar]
  8. Pfefferkorn ER, Borotz SE, Nothnagel RF. 1992. Toxoplasma gondii: characterization of a mutant resistant to sulfonamides. Experimental Parasitology, 74, 261–270. [CrossRef] [PubMed] [Google Scholar]
  9. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet, 364, 438–447. [CrossRef] [PubMed] [Google Scholar]
  10. Sauvage V, Aubert D, Bonhomme A, Pinon JM, Millot JM. 2004. P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii. Molecular and Biochemical Parasitology, 134, 89–95. [CrossRef] [PubMed] [Google Scholar]
  11. Sauvage V, Aubert D, Escotte-Binet S, Villena I. 2009. The role of ATP-binding cassette (ABC) proteins in protozoan parasites. Review. Molecular and Biochemical Parasitology, 167, 81–94. [CrossRef] [PubMed] [Google Scholar]
  12. Sauvage V, Millot JM, Aubert D, Visneux V, Marle-Plistat M, Pinon JM, Villena I. 2006. Identification and expression analysis of ABC protein-encoding genes family in Toxoplasma gondii. Molecular and Biochemical Parasitology, 147, 177–192. [CrossRef] [PubMed] [Google Scholar]
  13. Schmid A, Sauvage V, Escotte-Binet S, Aubert D, Terryn C, Garnotel R, Villena I. 2009. Molecular characterization and expression analysis of a P-glycoprotein homologue in Toxoplasma gondii. Molecular and Biochemical Parasitology, 163, 54–60. [CrossRef] [PubMed] [Google Scholar]
  14. Su C, Khan A, Zhou P, Majumdar D, Ajzenberg D, Dardé ML, Zhu XQ, Ajioka JW, Rosenthal BM, Dubey JP, Sibley LD. 2012. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proceedings of the National Academy of Sciences of the United State of America, 109, 5844–5849. [CrossRef] [PubMed] [Google Scholar]
  15. Ursing J, Zakeri S, Gil JP, Björkman A. 2006. Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran. Acta Tropica, 97, 352–356. [CrossRef] [PubMed] [Google Scholar]
  16. Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, Trenque T, Schmit G, Quereux C, Guenounou M, Pluot M, Bonhomme A, Pinon JM. 1998. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scandinavian Journal of Infectious Diseases, 30, 295–300. [CrossRef] [PubMed] [Google Scholar]
  17. Weiss LM, Dubey JP. 2009. Toxoplasmosis: a history of clinical observations. International Journal for Parasitology, 39, 895–901. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.